CellWell record HH-432962
Post-CAR T-cell thyroid dysfunction: destructive thyroiditis identified through thyroid function monitoring in a single-center cohort
Yoshiyuki Fujita; Kyoko Yoshihara; Nobuto Utsunomiya; Fuyuki Yamagata; Tomoko Kumamoto; Saki Takahashi; Mami Samori; Atsushi Katayama; Masahiro Teramoto; Takayuki Inoue; Katsuji Kaida; Tazuko Tokugawa; Akihiro Sawada; Satoshi Higasa; Hiroya Tamaki; Satoshi Yoshihara
2026
In plain language
Destructive thyroiditis occurred in 2 of 95 patients (2.1%) after CAR T-cell therapy, and both cases followed grade 2 or higher cytokine release syndrome, a possible association the authors describe as hypothesis-generating.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-432962
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.